Jakafi 10 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FSMF2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,990
Award facts
- Contract value 100% obligated
- $37,989.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37,989.81 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. This delivery order, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was issued without subcontractor involvement and will be performed at the awardee's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products to military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and runs through December 31, 2036, with a 30-month base period followed by three 30-month option periods. DMS Pharmaceutical Group serves as a critical regional prime vendor contractor supplying branded and generic prescription medications, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FSMF2?
SPE2DR26FSMF2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FSMF2 worth?
The government has obligated $37,990 on SPE2DR26FSMF2.
Is contract SPE2DR26FSMF2 an order under another contract?
Yes. SPE2DR26FSMF2 is a delivery order under SPE2DR25D9320, an indefinite delivery contract.
Was contract SPE2DR26FSMF2 competed?
The extent of competition for SPE2DR26FSMF2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award